Int. J. Environ. Res. Public Health 2009, 6 3141 65. Denny, M.F.; Atchison, W.D. Mercurial-induced alterations in neuronal divalent cation homeostasis. Neurotoxicology 1996, 17, 47–62. 66. Sirois, J.E.; Atchison, W.D. Effects of mercurials on ligand- and voltage-gated ion channels: A review. Neurotoxicology 1996, 17, 63–84. 67. Castoldi, A.F.; Coccini, T.; Ceccatelli, S.; Manzo, L. Neurotoxicity and molecular effects of methylmercury. Brain Res. Bull. 2001, 55, 197–203. 68. Shafer, T.J.; Meacham, C.A.; Barone, S., Jr. Effects of prolonged exposure to nanomolar concentrations of methylmercury on voltagesensitive sodium and calcium currents in PC12 cells. Brain Res. Dev. Brain Res. 2002, 136, 151–164. 69. Yoshida, M.; Satoh, M.; Shimada, A.; Yamamoto, E.; Yasutake, A.; Tohyama, C. Maternal-to- fetus transfer of mercury in metallothionein- pregnant mice after exposure to mercury vapor. Toxicology, 2002, 175, 215–222. 70. Gopal, K.V. Neurotoxic effects of mercury on auditory cortex networks growing on microelectrode arrays: A preliminary analysis. Neurotoxicol. Teratol. 2003, 25, 69–76. 71. Liu, J.; Liu, Y-P.; Habeebu, S.M.; Klaassen, C.D. Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex. Toxicol. Sci. 1998, 46, 197–203. 72. Liu, J.; Liu, Y.-P.; Goyer, R.A.; Achanzar W.; Waalkes, M.P. Metallothionein-I:II mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicol. Sci. 2000, 55, 460–467. 73. Stohs, S.J.; Bagchi, D. Oxidative mechanisms in the toxicity of metal ions. Free Radic. Biol. Med. 1995, 18, 321–336. 74. Shaikh, Z.A.; Vu, T.T.; Zaman, K. Oxidative stress as a mechanism of chronic cadmium-induced hepatotoxicity and renal toxicity and protection by antioxidants. Toxicol. Appl. Pharmacol. 1999, 154, 256–263. 75. Sabolic I. Common mechanisms in nephropathy induced by toxic metals. Nephron Physiol. 2006, 104, 107–114. 76. Yamanaka, K.; Hasegawa, A.; Sawunura, R.; Okada, S. Cellular response to oxidative damage in lung induced by the administration of dimethylarsenic acid, a major metabolite of inorganic arsenics, in mice. Toxicol. Appl. Pharmacol. 1991, 108, 205–213. 77. Barchowsky, A.; Dudek, E.J.; Treadwell, M.D.; Wetterhahn, K.E. Arsenic induces oxidant stress and NF-kB in cultured aortic endothelial cells. Free Radic. Biol. Med. 1996, 21, 783–790. 78. Liu, J.; Waalkes, M. Focal adhesion kinase as a potential target in arsenic toxicity. Toxicol Sci. 2005, 84, 212–213. 79. Yancy, S.L.; Shelden, E.A.; Gilmont, R.R.; Welsh, M.J. Sodium arsenite exposure alters cell migration, focal adhesion localization and decreases tyrosine phosphorylation of focal adhesion kinase in H9C2 myoblasts. Toxicol Sci. 2005, 84, 278–286. 80. Diaz-Barriga, F.; Llamas, E.; de Jesus Mejia, J.; Carrizales, L.; Santoyo, M.E.; Vega-Vega, L.; Yanez, L. Arsenic–cadmium interaction in rats. Toxicology 1990, 64, 191–203.